Bumetanide nasal spray (Corstasis Therapeutics)

N/A

Report date: 2026/02/04 15:16:05

Base Information

Drug NameBumetanide nasal spray (Corstasis Therapeutics)
Drug Alias NameEnbumystRSQ-777-02
ClassificationSmall molecules
Mechanisms of ActionSodium-(potassium)-chloride cotransporter 2 inhibitors
TargetsSodium-(potassium)-chloride cotransporter 2
Therapy Area/IndicationsEdemaHeart FailureKidney Diseases +[4] 
Global Approved IndicationsEdema
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/09/12
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCorstasis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCorstasis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEdemaHeart FailureKidney Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A